Dr. Andrew O. Wahl, MD

Dr. Wahl practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Wahl's NPI, 1124206602, was assigned on February 6, 2008. Dr. Wahl graduated from University of Nebraska College of Medicine in 2003. Dr. Wahl holds Illinois license 126047261.

Dr. Wahl's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Wahl also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Wahl's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Wahl is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wahl practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Wahl's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Wahl is licensed in Illinois.

CMS data shows 995 Medicare services from Dr. Wahl across 13 procedure codes in 2024, for 229 Medicare patients. Medicare paid $63,609 for them.

CMS counts 229 Medicare patients who saw Dr. Wahl in 2024. The largest group is 65 to 74, with 129 patients. 75% of them have cancer, and 72% have high blood pressure. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wahl's median patient age at 71, with 85% women.

In 2024, Dr. Wahl wrote 12 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $217 in total drug cost. In 2020, CMS named 11 claims across 1 drug.

Dr. Wahl accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Wahl, published from 2014 to 2022. 2016 was the busiest year, with 3. The most frequent topics are Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted and Organs at Risk. Dr. Wahl's most frequent co-authors are Michael J. Baine, MD, Charles A. Enke, MD and Chi Lin, MD.

Dmand AI links Dr. Wahl to 7 clinical trials, 4 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Breast Neoplasms, Male. NRG Oncology sponsors the most, 3.

CMS Open Payments shows 3 general payments to Dr. Wahl from 2 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $34.

Dr. Wahl graduated from University of Nebraska College of Medicine in 2003.